Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -46.56%30.06M | 12.38%12.84M | 117.93%20.04M | -96.20%1.13M | -167.22%-3.96M | 398.49%56.24M | -55.45%11.43M | 217.55%9.2M | 434.65%29.73M | 121.19%5.89M |
Net income from continuing operations | -143.24%-2.8M | 22.73%-3.41M | -30.88%3.12M | -53.81%2.16M | -378.25%-4.67M | -82.32%6.46M | -124.76%-4.42M | -73.86%4.52M | -11.32%4.69M | 143.56%1.68M |
Operating gains losses | 74.04%677K | 98.44%510K | 2,000.00%84K | --17K | --66K | -52.91%389K | -25.51%257K | --4K | ---- | ---- |
Depreciation and amortization | 19.46%20.25M | 25.50%5.76M | 22.46%5.28M | 14.07%4.78M | 14.78%4.44M | 14.75%16.95M | -2.67%4.59M | 28.31%4.31M | 12.32%4.19M | 30.14%3.86M |
Deferred tax | 9.64%-6.25M | 0.97%-6.24M | --0 | ---- | ---- | -25.43%-6.91M | -12.97%-6.3M | -223.79%-614K | ---- | ---- |
Change In working capital | -74.88%7.92M | -20.53%11.64M | 938.10%9.37M | -140.20%-7.83M | -255.13%-5.26M | 143.11%31.52M | 160.46%14.64M | 96.30%-1.12M | 197.29%19.47M | 94.81%-1.48M |
-Change in receivables | -84.39%11.37M | -61.31%3.92M | 297.06%10.51M | -102.88%-1.31M | -107.76%-1.75M | 177.52%72.86M | 136.22%10.13M | 89.97%-5.33M | 680.36%45.56M | 548.92%22.5M |
-Change in inventory | 220.36%5.99M | -109.55%-961K | 74.15%-3.59M | -58.30%3.34M | 178.76%7.2M | 84.91%-4.98M | -8.94%10.06M | -51.01%-13.9M | 174.44%8.01M | 62.00%-9.15M |
-Change in payables and accrued expense | 76.21%-6.85M | 310.59%9.38M | -80.89%2.88M | 62.95%-8.13M | 37.13%-10.99M | -176.08%-28.8M | -127.51%-4.46M | -27.77%15.06M | -1,556.04%-21.93M | -2,404.15%-17.48M |
-Change in other working capital | 65.74%-2.59M | 35.53%-704K | -114.00%-427K | 85.79%-1.73M | -89.86%268K | -147.29%-7.57M | -117.24%-1.09M | -73.08%3.05M | -317.46%-12.17M | 112.71%2.64M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -46.56%30.06M | 12.38%12.84M | 117.93%20.04M | -96.20%1.13M | -167.22%-3.96M | 398.49%56.24M | -55.45%11.43M | 217.55%9.2M | 434.65%29.73M | 121.19%5.89M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -189.84%-61.2M | 74.29%-1.18M | -885.45%-50.87M | 45.49%-3.51M | -14.16%-5.64M | -3.42%-21.11M | 27.86%-4.57M | -22.38%-5.16M | -47.06%-6.44M | 9.86%-4.94M |
Net PPE purchase and sale | 34.19%-13.57M | 52.42%-2.18M | 56.64%-2.24M | 45.49%-3.51M | -27.00%-5.64M | -0.97%-20.61M | 27.86%-4.57M | -22.38%-5.16M | -47.06%-6.44M | 18.98%-4.44M |
Net business purchase and sale | -9,426.20%-47.63M | --1M | ---48.63M | --0 | --0 | ---500K | --0 | --0 | --0 | ---500K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -189.84%-61.2M | 74.29%-1.18M | -885.45%-50.87M | 45.49%-3.51M | -14.16%-5.64M | -3.42%-21.11M | 27.86%-4.57M | -22.38%-5.16M | -47.06%-6.44M | 9.86%-4.94M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 200.66%36.96M | -155.76%-17.33M | 2,301.73%43.31M | 91.63%-1.91M | 352.20%12.9M | -369.04%-36.72M | 36.26%-6.77M | -123.71%-1.97M | -241.35%-22.87M | -2,482.32%-5.11M |
Net issuance payments of debt | 850.00%45M | -200.00%-15M | 350.00%45M | --0 | 66.67%15M | -110.71%-6M | 44.44%-5M | 0.00%10M | -200.00%-20M | -74.29%9M |
Net common stock issuance | 99.41%-113K | ---113K | --0 | --0 | --0 | 28.77%-19.08M | --0 | ---10.3M | ---21K | 67.28%-8.77M |
Cash dividends paid | 1.87%-6.98M | -2.15%-1.75M | -0.12%-1.74M | 0.56%-1.77M | 8.63%-1.72M | 0.55%-7.11M | 2.05%-1.72M | 0.91%-1.74M | -1.20%-1.78M | 0.42%-1.88M |
Proceeds from stock option exercised by employees | 78.77%-947K | -3,916.67%-458K | -28.99%49K | 86.09%-149K | 88.79%-389K | 46.99%-4.46M | -90.40%12K | 32.69%69K | 48.21%-1.07M | 46.80%-3.47M |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---69K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 200.66%36.96M | -155.76%-17.33M | 2,301.73%43.31M | 91.63%-1.91M | 352.20%12.9M | -369.04%-36.72M | 36.26%-6.77M | -123.71%-1.97M | -241.35%-22.87M | -2,482.32%-5.11M |
Net cash flow | ||||||||||
Beginning cash position | -13.78%9.96M | 117.09%21.44M | 14.73%8.96M | 79.60%13.25M | -13.78%9.96M | -68.92%11.55M | 245.07%9.88M | 18.18%7.81M | 99.89%7.38M | -68.92%11.55M |
Current changes in cash | 466.00%5.82M | -7,087.65%-5.66M | 503.58%12.48M | -1,098.37%-4.29M | 178.99%3.29M | 93.79%-1.59M | -99.07%81K | 155.22%2.07M | -85.25%430K | 87.54%-4.17M |
End cash Position | 58.48%15.78M | 58.48%15.78M | 117.09%21.44M | 14.73%8.96M | 79.60%13.25M | -13.78%9.96M | -13.78%9.96M | 245.07%9.88M | 18.18%7.81M | 99.89%7.38M |
Free cash flow | -53.83%16.4M | 55.95%10.66M | 343.22%17.8M | -110.30%-2.39M | -782.37%-9.68M | 190.11%35.51M | -64.61%6.84M | 133.36%4.02M | 273.68%23.24M | 104.26%1.42M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |